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Introduction
Head and neck tumours are detected mostly in an advanced stage 
and have poor prognosis. Due to anatomic complexity of the region 
complete surgical resection is rarely possible [1]. These in most cases 
histologically squamous cell- tumours are sensitive to radiation 
therapy. Prospective and randomized clinical trials have confirmed 
the central role of radiation therapy in the treatment of disease [2]. 
Precise radiation therapy treatment planning of tumours in this region 
is especially important as several organs of vital importance are located 
close to each other in a small area [3].
There is a large amount of evidence proving the efficacy of 
fluorodeoxy-glucose positron emission tomography (18F-FDG PET) 
during detection of unknown primary, staging of disease, restaging 
after salvage surgery or neck block dissection as well as in assessment 
of response to therapy in head and neck cancer [4-7]. There is also 
growing interest in utilizing 18F-FDG PET in growth target volume 
delineation for radiation therapy planning in this sensitive region 
[8]. 18F-FDG PET offers delineation and precise contouring of the 
biologically active tumour -based on metabolic information- essential 
for effective treatment. It also allows for potential identification of 
lymph nodes missed by conventional computer tomography (CT) and 
magnetic resonance imaging (MRI) imaging [9]. Nevertheless the use 
of 18F-FDG PET in this regard is still under study, due to lack of good 
spatial and temporal resolution, questionable reproducibility [10]. 
According to current guidelines target volume delineation for radiation 
therapy planning is recommended by CT supplemented by MRI certain 
cases [10].
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Abstract
Introduction: Aim of the current study was to compare gross tumour volume delineation for radiation therapy 
planning by PET/CT and CT scan in head and neck tumour patients. 
Methods: 70 oncological patients with primary head and neck cancer were enrolled in the study. CT and 18F-FDG-
PET/CT scans were performed within 3 weeks of enrolment in the planned irradiation position. For radiation therapy 
planning delineation of the target volumes was performed manually both in conventional topometric CT slides and 
in FDG-PET/CT images. Gross tumour target volume was calculated (GTVcm3) using both modalities. Numerical 
and geometrical (intersection divided union ratio) comparisons were assessed. Intraobserver, interobserver, and 
intermodality variation analyses were performed. 
Results: Intra- and interobserver agreement (intraclass correlation coefficients: 0.99 and 0.97) of tumour 
volume delineation with 18F-FDG-PET/CT was excellent. Radiotherapy target volume as assessed by FDG-PET/
CT differed in 98% (69/70) from target volumes calculated by the CT scans. According to the metabolic information, 
the target volume was larger in 12 cases (18%) and smaller in 58 cases (82%). Significant differences were found 
between CT and PET/CT based tumour volume (paired t-test, p<0.0001). Intersection divided union ratio showed 
low overlap (0.32). 
Conclusions: Tumour delineation for radiation therapy planning with PET/CT shows good reproducibility in 
patients with head and neck cancer. CT based morphologic information compared to PET/CT overestimates the 
tumour volume in larger lesions and may underestimate it in smaller target lesions. Differences are not only evident 
in tumour volume, but in geometry: Morphology of tumour volume and position.
Integrated 18F-FDG PET/CT imaging with combined morphological 
and metabolic information has the potential of improving radiotherapy 
planning, gross tumour volume (GTV) delineation. However 
there is currently no consensus on methods of delineation, volume 
definition or in regards to overall utility of 18F-FDG-PET/CT scans in 
radiotherapy planning of in head and neck cancer patients. This field 
remains an active area of research [11]. The present work aims to study 
the reproducibility of tumour volume determination by 18F-FDG-PET/
CT, and to compare it to the current standard contouring by CT scan in 
head and neck cancer patients.
Patients and Methods
We enrolled 70 patients undergoing radiation therapy planning 
for head and neck cancer (Group 1) in the current study. The average 
age of the patients was 58 ± 9 years (19-77 years). 20% of the studied 
patients (14/70) were women and 80% (56/70) were men. Histological 
distribution was the following: (94.3%; 66/70 patients) squamous 
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was completed by plain low-dose CT (130 kV and 70 mAs) mapping. 
The PET scan was performed in three dimensional (3D) modes for 2 to 
4 minutes per bed position, and the field of view was 21 cm with 25% 
overlap. The 3D images were reconstructed by using an iterative process 
with resolution enhancement technology (point spread function 
correction) in a 336 × 336 pixel matrix. After imaging the head and 
neck region, and removing the mask, a routine whole-body mapping 
was performed extending from the skull base to the upper third of the 
thighs.
GTV was manually delineated in each patient with both modalities. 
GTV selection for treatment planning was manually performed on 
both the conventional CT based topometric slides (GTVCT) and the 
PET/CT registered images (GTVPET) by a skilled radiologist and by a 
nuclear medicine specialist independently. XIO 3D planning system 
(Elekta Ltd, Crawly, UK) was used for evaluation. GTVCT contouring on 
the radiation planning CT was performed according to the guidelines 
of the Department of Oncotherapy. Available images of former contrast 
CT or MRI scans were reviewed under the supervision of a radiologist. 
Tumour volumes were recorded and determined in units of cm3 (Figure 1).
In each case, the GTV volume based on the performed 18F-FDG-
PET/CT scan was compared to the GTV provided by the CT scan and 
their difference was described both in cm3 and in percentage. For the 
geometric comparison of each tumour volume of interest (VOI), the 
Intersection/Union (I/U) ratio was calculated. The I/U quotient is 
a ratio which ranges from 0 to 1. In case of full overlap, the I/U is 1, 
whereas in full diversity, the I/U is 0. For example, I/U=0.33 means 
a 50% overlap of two equal volumes (Figure 2). The total patient 
population (Group 1), was divided into subgroups based on differences 
in GTV of the two modalities (Group A: GTVPET-CT>GTVCT; Group B: 
GTVPET-CT ≤ GTVCT). The before mentioned volumetric and geometrical 
comparisons were repeated in both subgroups.
cell carcinomas, 3 adenocarcinomas (4.2%), and 1 patient had 
neurofibrosarcoma (1.5%).
Interobserver and intraobserver variance analyses were performed 
on the 18F-FDG-PET/CT scans of 16 randomly selected patients (Group 
2). In this group, the average age of patients was 58 years (44-73 years), 
and the male to female ratio was 16:0. Histology examination confirmed 
squamous cell carcinoma in all 16 patients. The locations of tumours 
are listed in Table 1.
Image acquisition protocol was the following. During patient 
preparation the head and neck region was positioned with four or 
five-point thermoplastic masks. Treatment planning CT (topo CT) 
was carried out according to standard protocols (Siemens Emotion 6 
CT), 512*512 matrix, and 5-3 mm slice thickness. After CT imaging, 
18F-FDG-PET/CT scan was performed within 3 weeks in the same 
patient position using thermoplastic fixation (SIEMENS Biograph 6 
HD, Siemens Knoxville TN). After 6-hours fasting 3.7 MBq/kg 18F-FDG 
radiopharmaceutical was administrated intravenously. Blood glucose 
levels were checked beforehand (capillary blood via fingerstick, serum 
blood glucose <8 mmol/L). Imaging of the head and neck region was 
carried out 60 minutes after the administration of the radioisotope in 
the irradiation position, which was identical to the patient's topo CT 
positioning with thermoplastic mask fixation. PET scan data collection 
Table 1: Primary localization of head and neck tumours. Patient Group 1: The total 
population; Patient Group 2: Subgroup of the total population randomly selected for 
intra- and interobserver analyses.
Tumor localization Patient Group 1 n=70 Patient Group 2 n=16
Oral cavity and larynx 25 6
Nasopharynx 6 4
Oropharynx, hypopharynx 33 6
Nasal cavity and nasal sinuses 3
Figure 1: Interobserver analysis of 18F-FDG PET/CT gross tumour volume delineation. Axial (A), sagittal (B) and coronal slices (C) of fused 18F-FDG PET/CT images 
and 3D Gaussian filtered contours (D) of a head and neck cancer patient. Each observer delineated the primary tumour. Contours from the three observers are shown 
in different colors. Red: 2.08 cm3, yellow: 1.38 cm3, blue: 0.87 cm3; I/U ratio: 0.41.
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Figure 2: Schematic illustration of geometric comparison using intersection union. (A) I/U=0 means no overlap, (B) partial overlap I/U=0.33. On both (C) and (D) pictures 
the I/U=0.20 highlighting the fact that both shape and position influence I/U values. 
For 18F-FDG-PET/CT intraobserver and interobserver variation 
analyses of manual contouring 20 solid lesions with different size were 
evaluated in the scan images of 16 randomly selected patients (Group 
2). Three experienced observers (A, B, C) determined the macroscopic 
tumour volume independently, with the use of the Medical Imaging 
Interaction Toolkit (MITK, German Cancer Research Centre) software. 
Primary tumour contouring was performed in the axial slides of 
18F-FDG PET scans. The contours were finalized with the help of 
CT images taking patient anatomy into consideration, and the GTV 
was also determined in cm3. Observer 'A' repeated the manual GTV 
delineation described above on two more occasions in random order 
within a week. Evaluating physicians were blinded to the patient’s 
clinical data and results of other imaging tests. To determine geometric 
interobserver and intraobserver differences, the I/U ratio was also 
calculated in both in the case of observers A, B and C (Figure 3), and in 
settings A1, A2 and A3.
Data analyses was performed with R Statistical Software version 
343 (The R foundation for statistical computing, Vienna, Austria). Data 
were reported as mean ± standard deviation and range in parenthesis 
where appropriate. P<0.05 was considered to be statistically significant. 
Values for I/U were interpreted in the following way: 0.8-1: excellent, 
0.5-0.8: good, 0.33-0.50: moderate and 0.0-0.33: low. Applied statistical 
methods: Paired t-test and unpaired two-sample Wilcoxon Rank test 
for comparisons of GTVCT and GTVPET-CT as applicable and intraclass 
correlation for inter and intraobserver differences.
The scheme of experiments complied with the ethics of research. 
It agreed with the declaration of the Medical World Federation 
proclaimed in Helsinki in 1964, therefore, the Human Investigation 
review Board did not raise any objection to it from ethical point of 
view and supported it. Reference number: 3647, name of the ethics 
committee: Human Investigation Review Board, University of Szeged, 
Hungary.
Results
Comparison of radiation therapy target volumes delineated 
by 18F-FDG PET/CT and CT
Tumour volumes were identical in 1 out of 70 cases (1%), decreased 
in size in 57 cases (81%) of the cases, and increased in 12 cases (18%) of 
the cases, when the results acquired by the 18F-FDG-PET/CT scan were 
compared to the results defined by topo-CT scan. Tumour volumes 
defined by the two different imaging modalities were non-identical in 
99% of the cases. In 11 out of 70 cases, the difference in the percentage 
of volumes was lower than 10%. The difference in the percentage of 
volumes was higher than 10% in 59 out of 70 patients (84% of all 
patients). Tumour volume defined by the 18F-FDG-PET/CT was 
significantly smaller (paired T test, p<0.0001) than tumour size defined 
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± 0.12 in overall comparison of the members in the three series. For 
intraobserver comparison difference in volumes (A1, A2, and A3) was 
1.12 ± 1.1 cm3 that is 12.31 ± 7.4%. The intraclass correlation coefficient 
was 0.9903. The average I/U ratio concerning A1-A2-A3 combined was 
0.76 ± 0.08.
Discussion
In the current study we report significant differences in tumour 
target volume and geometrical position as assessed by 18F-FDG-
PET/CT and CT in patients with head and neck cancer undergoing 
radiation therapy planning. Defining the “real” volume of malignant 
tumours precisely in a standard, reproducible manner is still a 
challenge for diagnostic experts and radiotherapists. The variability in 
the defined tumour volume is particularly important in case of head 
and neck tumours, where there is a relatively large irradiation dose 
(70 Gray) applied in a small area. An inappropriately identified target 
volume results in an extensive marginal error of irradiation. Applying 
decreased irradiation to certain parts of the target volume, may lead 
to worsening prognosis of the disease (marginal recurrence). On 
the other hand inaccurate protection of tumour free areas, may lead 
to increasing severity of adverse effects [12]. Morphologic studies 
(CT and MRI scans) and functional imaging techniques (18F-FDG-
PET) provide different information about the studied region, the 
tumour, and adjacent tissues. While computer tomography provides 
Figure 3: Intermodality differences of gross tumour volume delineation. Axial (A), sagittal (B) and coronal slices (C) of fused 18F-FDG PET/CT images and 3D Gaussian 
filtered contours (D) of a head and neck cancer patient (hypopharynx). Contours of the two modalities are shown in different colors (red - GTVCT, yellow - GTVPET/CT). 
Red: 12.2 cm3, yellow: 8.8 cm3; I/U ratio: 0.44. 
by the topo-CT scan: GTVCT: 52.54 ± 51.11 cm
3 (1.80-208.50 cm3), 
GTVPET-CT: 33.16 ± 39.78 cm
3 (1.00-188.40 cm3). Difference in volume 
(independent of in which modality was higher or lower) was 22.33 ± 
23.33 cm3 (0.40-116.00 cm3), which describes a difference of 53.77% ± 
40.94% (0.55-213.25%). During geometrical analyses I/U were 0.32 ± 
0.19 (0.03-0.77). Results of volumetric and geometrical comparisons of 
Group A (GTVPET-CT > GTVCT) and Group B (GTVPET-CT ≤ GTVCT) are 
presented in Table 2. To further examine the effects of tumour size on 
differences in radiation therapy target volumes delineated by 18F-FDG 
PET/CT and CT a cut-off value of 37 cm3 GTVCT was established. In all 
patients where GTVCT was higher than 37 cm
3 (n=32) GTVCT was larger 
than GTVPET-CT (paired t test, p<0.05).
Interobserver and intraobserver variance analyses of 
18F-FDG-PET/CT tumour delineation
Macroscopic tumour volume delineated in Group 2 during the 5 
measurements (A1, A2, A3, B, and C) was 13.20 ± 13.43 cm3 (0.60-54.20 
cm3). During interobserver comparison (A1, B, and C), the average 
difference in measured volume was 3.08 ± 2.36 cm3 (0.10-5.56 cm3), 
which described a difference of 29.49 ± 18.00% (5-78%). The intraclass 
correlation coefficient was 0.9724. Higher differences in percentage 
(46.75 ± 20.25% vs. 20.19 ± 9.17%, unpaired two-samples Wilcoxon 
Rank Sum test p<0.05) were characteristic mostly for tumours of 
smaller size (<5 cm3). The geometric intersection union ratio was 0.68 
 Group N GTVCT  (cm3)* GTVPET/CT  (cm3) NS Difference in (cm3)* Difference in percentage (%) NS I/U NS
Group A
GTVPET/CT>GTVCT
12/70 13.42 ± 11.00 (1.80-36.8) 22.03 ±17.15 (3.30-54.20) 8.62 ± 9.49 (0.80-26.5) 81.26 ± 72.75 (6.29-213.25) 0.35 ± 0.20 (0.08-0.77)
Group B
GTVPET/CT ≤ GTVCT
58/70 60.63 ± 52.44 (5.50-208.5) 35.46 ± 42.75 (0.20-188.4) 25.17 ± 24.48 (0.4-116.00) 48.08 ± 28.55 (0.55-99.37) 0.26 ± 0.15 (0-0.51)
Table 2: Comparison of subgroups defined by differences found between18F-FDG PET/CT and CT gross tumour volume. Group A represents patients where GTVPET/CT 
was larger than GTVCT; Group B represents patients where GTVPET/CT was smaller than GTVCT. Data are presented as mean ± standard deviation with range in brackets. 
*:(Wilcoxon Rank test, p<0.05); NS: not significant.
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high morphological image resolution according the radioabsorption 
of tissues, the visualized contrast between the various soft tissues is 
relatively poor. On the contrary, 18F-FDG-PET scan provides prominent 
visualization in contrast of functional information of studied tissues, 
but the morphological image resolution is limited. The advantages of the 
two methods are combined by the hybrid PET/CT imaging modality.
Validation of tumour volumes by pathology specimens using several 
imaging modalities has been attempted [13]. compared CT, MRI and 
FDG-PET scan results of 29 patients with head and neck tumour to 
their surgical specimen. The size of GTVs delineated by CT scan ranged 
between 1.9 and 137.7 cm3, which was similar to our findings. However, 
in our study, slightly larger tumours were identified. According to 
Daisne results, the surgical specimens were significantly smaller in 
size compared to the results of all three imaging studies (CT=20.8 
cm3, MRI=23.8 cm3, PET=16.3 cm3, and surgical specimen=12.6 cm3). 
FDG-PET scan revealed significantly smaller volume than the other 
two modalities, and it showed the best correlation with pathology 
results. In terms of GTVCT and GTVPET, it was identical to our results 
[14]. compared CT and 18F-FDG-PET/CT scan images of 16 patients to 
tumour volume determined by the pathology. According to their study, 
both CT and 18F-FDG-PET/CT scan overestimated the tumour volume 
compared to the specimen; however, 18F-FDG-PET/CT scan results 
were closer to those of the specimens. In the meta-analysis of Huang et 
al. [15], data of 717 patients with head and neck tumour were processed; 
both the irradiation target volume and the pathology tumour volume 
were determined for all patients by at least two imaging modalities 
(MRI, CT, or 18F-FDG-PET/CT). Their results showed that the CT-
based GTV was larger than the MRI and PET scan-based volume, while 
GTVPET significantly correlated with the pathology tumour volume.
The role of 18F-FDG-PET/CT scan in head and neck tumour in the 
clinical setting of irradiation therapy has also been studied, albeit in 
smaller number of patients then in our study and with heterogeneous 
results [16-18]. Our results show significant differences in GTVs 
defined by functional and morphological methods, similarly to previous 
publications. We also report that heterogeneity of these differences is in 
part related to tumour size. In the current patient group larger PET/CT 
derived GTV-s as compared to CT were less common and only found 
in small lesions as defined by CT. Whereas larger CT derived GTV-s 
as compared to PET/CT were more common, larger, however also 
heterogeneous in size (Table 2). Further examining the effects of tumour 
size a cut-off point of 37 cm3 CT derived GTV could be established. 
In all cases where tumour size was larger than the cut off volume, 
metabolic information of 18F-FDG-PET/CT reduced radiotherapy 
gross target volume. Possible cause behind this phenomenon may be 
inflammation and oedema surrounding larger tumours falsely included 
by CT in the primary tumour volume. Ciernik et al. also raised the 
question of tumour size effecting heterogeneous results but failed to 
show significant differences probably due to small sample size [16]. 
Paulino et al. analyzed 40 patients with head and neck cancer and found 
similarly to our results that the tumour size reduced in most cases as 
defined by 18F-FDG-PET/CT scan (in 30 out of 40 patients), whereas an 
increase in GTV compared to the results of the CT scan was identified 
only in 7 patients. In accordance with our experience, this study also 
found that in the case of relatively large tumours, 18F-FDG-PET/CT 
reduced the GTVCT in 75% of the cases [17].
Along with others our results support the view that morphological 
tumour volume delineation is significantly different from the metabolic 
tumour volume, and the difference is even more marked if volume 
geometry is also considered. The accuracy of tumour delineation by the 
different imaging techniques is not only determined by tumour volume 
given in cm3. Two tumours of completely equal volume (e.g., two 
tumours of 2 cm3) may be different in shape and localization. During 
comparison measurements, not only the difference in the size (cm3) of 
the tumour should be considered, but also differences in localization 
and shape. We used, similarly to several other authors, the I/U ratio 
to compare the individual tumour volumes, and identified a great 
variety of the quotient [19-21]. Anderson et al. analyzed the manually 
delineated tumour volumes based on findings of CT, FDG-PET/CT 
and MRI (post contrast T1) scans performed for establishing the plain 
irradiation treatment plan in 14 patients with head and neck tumour 
[21]. Similarly to their work, we also examined the geometrical match 
between the results of the different modalities besides and found low 
overlap.
Contouring which may also influence results is complicated by 
several factors in case of both imaging technique. In CT scans, the 
consequences of the postoperative condition may leave asymmetry and 
scarring. In metabolic FDG-PET scans, the areas with physiological 
FDG uptake may also show diversity. In the head and neck region, there 
may be a physiological, moderate increase in glucose metabolism in 
the adenoid and lymphoid tissues, in the nasopharynx, soft palate, and 
tonsils (lingual and palatine), and in the salivary glands. An increased 
uptake of the radiopharmaceuticals in the vocal cords bilaterally and 
in the tongue might refer to speaking (muscle activity) during tracer 
accumulation time, and symmetrical uptake in the eye muscles may 
refer to eye movements, which are both considered being normal. For 
these reasons, the assessment of 18F-FDG-PET and CT scans, and the 
recognition of abnormalities in the head and neck region require skills 
and practice in hybrid imaging. Riegel et al. found tumour contouring 
based on 18F-FDG-PET/CT scan to be more reproducible, as opposed 
to the target volume defined solely by CT scan [22]. Several further 
studies have shown in case of head and neck tumours co-registered 
anatomic and metabolic images provide significantly more accurate 
tissue contouring than CT scan alone [23]. This is also true for imaging 
of specified organs at risk [24]. Vinod et al. processed the data of 56 
studies in their met
a-analysis, and found that observer-dependent differences can 
be reduced by learning, teaching, and using uniform standards [20]. 
Semiautomatic contouring based on various techniques seems also to 
reduce the differences [25]. Our intraobserver variance analysis showed 
that 18F-FDG-PET/CT manual contouring was well-reproducible if 
the assessment was performed by the same person. Similarly to data 
in literature, interobserver analyses reproducibility was somewhat 
lower but still excellent [18,20]. Furthermore, intra and interobserver 
comparisons were also made taking into account not only volumetric 
but geometric results (tumour overlap) as well. Intra and interobserver 
agreement remained good by 18F-FDG-PET/CT manual contouring 
even when geometric differences were considered.
The current study shares all the inherent limitations of retrospective 
studies. This study was aimed at the determination of the primary 
tumour volume. The effect of the PET/CT scan was not evaluated 
separately on the changes in staging, and whether previously 
undetected potential lymph node metastases were revealed. Due to the 
heterogeneity of tumour stages in the relative low number of patients 
the study was underpowered for clinical follow-up. Although several 
steps were taken to ensure uniform patient preparation and image 
acquisition, small differences caused by patient movement/position 
alternation cannot be ruled out.
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In conclusion manual tumour contouring of 18FDG-PET/CT images 
provides excellent intra- and interobserver reliability in head and neck 
cancer patients. CT based morphologic information compared to 
PET/CT overestimates the tumour volume in larger lesions and may 
underestimate it in smaller target lesions during radiation therapy 
planning. The differences in the results of functional imaging studies 
and the CT scans are not merely due to the differences in the size, but to 
the geometrical differences in the morphology of tumour volume and 
position. Prospective randomized large studies are needed to evaluate if 
these imaging modality based differences in radiation therapy planning 
influence clinical outcomes in head and neck cancer patients.
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